18) Viral Vaccines
Abstract
Evaluate the best vaccine candidates for Alphaviruses and Filoviruses for effectiveness and duration of protective immune response against aerosol challenge in large animal models. Animal models will be developed to support FDA licensure of mature vaccine candidates. This effort is transitioning to the Bacterial, Viral and Toxin Prophylaxis thrust area starting in FY21.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2022
- Source ID
- 38d71ca3a4eb0f6c85b1c3c7b167ed31